{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:36:06Z","timestamp":1793144166529,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.surg.2012.05.031","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T12:15:45Z","timestamp":1341576945000},"page":"S13-S18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"S","title":["Targeting the MAGE A3 antigen in pancreatic cancer"],"prefix":"10.1016","volume":"152","author":[{"given":"Alexandria P.","family":"Cogdill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennie T.","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haven R.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Ferrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Thayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Warshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Wargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2012.05.031_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJM199202133260706","article-title":"Pancreatic carcinoma","volume":"326","author":"Warshaw","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2012.05.031_bib2","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","article-title":"Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma","volume":"23","author":"Dudley","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2012.05.031_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.surg.2012.05.031_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.surg.2012.05.031_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejcts.2003.09.015","article-title":"Melanoma associated antigen (MAGE)-A3 expression in Stages I and II non-small cell lung cancer: results of a multi-center study","volume":"25","author":"Sienel","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"issue":"Suppl 2","key":"10.1016\/j.surg.2012.05.031_bib6","doi-asserted-by":"crossref","first-page":"B61","DOI":"10.1016\/j.vaccine.2007.06.038","article-title":"GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development","volume":"25","author":"Brichard","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.surg.2012.05.031_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2217\/1750743X.1.1.19","article-title":"MAGE A3 antigen-specific cancer immunotherapeutic","volume":"1","author":"Peled","year":"2009","journal-title":"Immunotherapy"},{"key":"10.1016\/j.surg.2012.05.031_bib8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4049\/jimmunol.1001775","article-title":"A\u00a0TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer","volume":"186","author":"Chinnasamy","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.surg.2012.05.031_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.2001.19.1.145","article-title":"Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation","volume":"19","author":"Jaffee","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2012.05.031_bib10","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1182\/blood.V93.12.4309","article-title":"Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies","volume":"93","author":"Brossart","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.surg.2012.05.031_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2007.01.003","article-title":"Potential target antigens for immunotherapy in human pancreatic cancer","volume":"252","author":"Schmitz-Winnenthal","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.surg.2012.05.031_bib12","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/ijc.21656","article-title":"The clinical significance of MAGEA3 expression in pancreatic cancer","volume":"118","author":"Kim","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.surg.2012.05.031_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ijc.2910630313","article-title":"Expression of MAGE genes in primary and metastatic cutaneous melanoma","volume":"63","author":"Brasseur","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.surg.2012.05.031_bib14","first-page":"1","article-title":"The cancer\/testis genes: review, standardization, and commentary","volume":"4","author":"Scanlan","year":"2004","journal-title":"Cancer Immun"},{"key":"10.1016\/j.surg.2012.05.031_bib15","first-page":"6682","article-title":"MAGE-A gene expression pattern in primary breast cancer","volume":"61","author":"Otte","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2012.05.031_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1440-1827.2003.01605.x","article-title":"Expression of MAGE-A3 in intrahepatic cholangiocarcinoma and its precursor lesions","volume":"54","author":"Tsuneyama","year":"2004","journal-title":"Pathol Int"},{"key":"10.1016\/j.surg.2012.05.031_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1034\/j.1600-065X.2002.18803.x","article-title":"Cancer\/testis antigens: an expanding family of targets for cancer immunotherapy","volume":"188","author":"Scanlan","year":"2002","journal-title":"Immunol Rev"},{"key":"10.1016\/j.surg.2012.05.031_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000055905","article-title":"Expression spectrum and methylation-dependent regulation of melanoma antigen-encoding gene family members in pancreatic cancer cells","volume":"2","author":"Bert","year":"2002","journal-title":"Pancreatology"},{"key":"10.1016\/j.surg.2012.05.031_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1568011033482440","article-title":"The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells","volume":"3","author":"Zhu","year":"2003","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"10.1016\/j.surg.2012.05.031_bib20","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"27","author":"Lane","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2012.05.031_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1479-5876-9-37","article-title":"Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer","volume":"9","author":"Fujisawa","year":"2011","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.surg.2012.05.031_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2009-03-211714","article-title":"Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.surg.2012.05.031_bib23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2012.05.031_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.surg.2012.05.031_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2217\/1750743X.1.2.223","article-title":"Monoclonal antibodies in the treatment of pancreatic cancer","volume":"1","author":"Huang","year":"2009","journal-title":"Immunotherapy"},{"key":"10.1016\/j.surg.2012.05.031_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/SLA.0b013e3181fd271c","article-title":"A\u00a0lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation","volume":"253","author":"Lutz","year":"2011","journal-title":"Ann Surg"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606012002395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606012002395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:49:56Z","timestamp":1758538196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606012002395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0039606012002395"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2012.05.031","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the MAGE A3 antigen in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2012.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}